SUMMARY Maternal chlamydial antibodies were determined in cord sera of 41 infants who developed neonatal chlamydial conjunctivitis and compared with the antibody profile of infants who had been exposed to Chlamydia trachomatis at birth by their isolation positive mothers but in whom conjunctivitis did not develop. No protective effect could be attributed to maternal antibodies transferred to the infants. Paired sera samples were collected from 18 infants with chlamydial conjunctivitis. Chlamydial IgM antibodies were detected in four of these 18 cases at the time diagnosis was established by isolation. An additional eight cases had developed chlamydial IgM at the time the convalescent sera samples were taken, on average on day 40. At that time symptoms had disappeared after systemic treatment had been given. Thus chlamydial IgM antibodies were eventually shown in two thirds of infants with chlamydial conjunctivitis who were all systemically treated and clinically healed. These data suggest a cautious assessment of chlamydial IgM in the diagnosis of chlamydial pneumonia.
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Neonatal chlamydial infection may occur when the mother has a genital infection by Chlamydia trachomatis. The prevalence of genital chlamydial infection in pregnant and puerperal women ranges between 2 and 18% in different populations.' 7 The most common clinical manifestation of neonatal chlamydial infection is conjunctivitis, which is observed in 20-35% of exposed infants. C. trachomatis can, however, be recovered from several locations besides the conjunctivae-that is, nasopharynx, gastrointestinal tract, and vagina. 
Discussion
Chlamydial IgG antibodies were detected in 40 of 41 samples of cord sera taken from infants with neonatal chlamydial conjunctivitis, and neither the prevalence of antibodies nor the geometric mean titre differed from the infants without conjunctivitis whose mothers had proven genital chlamydial infection 3-4 days after delivery. Therefore, transferred maternal serum antibodies did not seem to confer any detectable protection against chlamydial infection of the conjunctivae. The mean age of the mothers of the 41 infants with chlamydial conjunctivitis was 24 compared with 23 for the mothers infected with chlamydia with asymptomatic infants. Thus there was no indication that any resistance factor related to age of the mothers might have determined the subsequent clinical eye manifestations in the children with chlamydial conjunctivitis.
Experimental chlamydial eye infections in volunteers have shown partial immunity to the homologous chlamydial strain.16 17 Systemic immunity seemed to be more important than local immunity in those experiments. Antibodies to a genus antigen determined by complement fixation present before the challenge did not prevent infection. This antibody reactivity reflected previous exposure to any of the 15 serovars of C. trachomatis or even to the ornithosis agent, Chlamydia psittaci. Our results are not directly comparable as the infants in our study had maternally transferred antibodies, which should be expected to be homologous to the infecting strain.
In several different studies the attack rate of clinical chlamydial conjunctivitis has been estimated to be 20-35% of exposed infants in populations where the prevalence of natural chlamydial infections has varied between 2-18%. Even in Nairobi, 
